DegenRx B.V.
Tilburg · Founded 2018
About DegenRx B.V.
DegenRx is a biopharmaceutical company that develops therapeutic solutions to treat neurodegenerative diseases.
Company Facts
- Founded: 2018
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2018)
- Website: degenrx.com
Social Profiles
Canonical: https://fsome.com/organization/degenrx-b-v-8302803 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.